Showing results (321-330 of 743) with videos related to

Sort By:
Pageof 75
BMC Gastroenterology|November 5, 2016
Increased mortality among men aged 50 years old or above with elevated IgA anti-transglutaminase antibodies: NHANES IIIAlberto Rubio-Tapia, Jonas F Ludvigsson, Rok Seon Choung, et al.
Basic Research in Cardiology|May 22, 2009
Prevention of vasa vasorum neovascularization attenuates early neointima formation in experimental hypercholesterolemiaMario Gössl, Jörg Herrmann, Hui Tang, et al.
The Journal of Applied Laboratory Medicine|May 26, 2023
Kappa Free Light Chain Drift Prompts the Need for a New Upper Limit of Normal Free Light Chain Ratio to Avoid an Epidemic of Kappa Light Chain Monoclonal Gammopathy of Undermined SignificanceKrasimira Rozenova, Maria Willrich, Melissa Snyder, et al.
American Journal of Hematology|October 26, 2017
Efficacy of VDT PACE-like regimens in treatment of relapsed/refractory multiple myelomaArjun Lakshman, Preet Paul Singh, S Vincent Rajkumar, et al.
American Journal of Hematology|January 11, 2022
Multicentric Castleman disease: A single center experience of treatment with a focus on autologous stem cell transplantationNadine H Abdallah, Thomas Habermann, Francis K Buadi, et al.
Bone Marrow Transplantation|December 23, 2017
Impact of prior melphalan exposure on stem cell collection in light chain amyloidosisSurbhi Sidana, Nidhi Tandon, Morie A Gertz, et al.
Blood|January 7, 2006
Absolute values of immunoglobulin free light chains are prognostic in patients with primary systemic amyloidosis undergoing peripheral blood stem cell transplantationAngela Dispenzieri, Martha Q Lacy, Jerry A Katzmann, et al.
Blood Advances|November 23, 2018
Plasma cell proliferative index is an independent predictor of progression in smoldering multiple myelomaMohammed A Aljama, M Hasib Sidiqi, Arjun Lakshman, et al.
British Journal of Haematology|July 13, 2019
Ten-year survivors in AL amyloidosis: characteristics and treatment patternEli Muchtar, Morie A Gertz, Martha Q Lacy, et al.
Blood Advances|July 27, 2026
Self-Reported Geriatric Impairments and Treatment Toxicity in Older Patients with Multiple Myeloma-A Single Center Prospective StudyNadine Abdallah, Rosalyn Marar, Claire I Yee, et al.
Pageof 75